{"disease":{"id":"generalized-epilepsy","name":"generalized epilepsy"},"drugs":{"marketed":[{"drug_id":"perampanel","indication_name":"Idiopathic generalized epilepsy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fycompa","generic_name":"PERAMPANEL","company_name":"Catalyst Pharms","drug_phase":"marketed","molecular_target":"Glutamate receptor ionotropic AMPA","drug_class":"Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]","quality_score":75,"revenue":"300","mechanism":"Fycompa works by blocking the AMPA glutamate receptor, which is involved in the transmission of nerve impulses."},{"drug_id":"bat","indication_name":"Treatment of primary generalized tonic-clonic seizures in patients 2 years of age and older with epilepsy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bat","generic_name":"bat","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Unknown","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"lacosamide","indication_name":"Idiopathic generalized epilepsy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vimpat","generic_name":"lacosamide","company_name":"UCB","drug_phase":"marketed","molecular_target":"Dihydropyrimidinase-related protein 2, Carbonic anhydrase 1, Carbonic anhydrase 12","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"fycompa","indication_name":"Idiopathic generalized epilepsy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fycompa","company_name":"Eisai Inc.","drug_phase":"marketed","molecular_target":"Glutamate receptor ionotropic AMPA","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04252846","title":"A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy","phase":"","overall_status":"COMPLETED","enrollment_count":191,"lead_sponsor_name":"Eisai Limited","has_results":false},{"nct_id":"NCT06393309","title":"Levetiracetam Versus Valproate in Idiopathic Generalized Epilepsy","phase":"","overall_status":"COMPLETED","enrollment_count":169,"lead_sponsor_name":"Mazandaran University of Medical Sciences","has_results":false},{"nct_id":"NCT03678753","title":"Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":169,"lead_sponsor_name":"SK Life Science, Inc.","has_results":false},{"nct_id":"NCT04439656","title":"Detecting Absence Seizures Using Eye Tracking","phase":"","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Rachel Kuperman","has_results":false},{"nct_id":"NCT03590197","title":"Effect of Melatonin on Seizure Outcome, Neuronal Damage and Quality of Life in Patients With Generalized Epilepsy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":104,"lead_sponsor_name":"All India Institute of Medical Sciences, Bhubaneswar","has_results":false},{"nct_id":"NCT03457961","title":"Post-market Study of AMPA Receptor Antagonists for Epilepsy Patients in Hong Kong","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT05530109","title":"Study of Attentional Disorders in Patients Suffering From Idiopathic Generalized Epilepsy.","phase":"","overall_status":"TERMINATED","enrollment_count":33,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT05393518","title":"Electroclinical Correlation of Anxiety","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT06425159","title":"A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":27,"lead_sponsor_name":"Biohaven Therapeutics Ltd.","has_results":false},{"nct_id":"NCT06797791","title":"Assessment of Multifocal Continuous Theta Burst Transcranial Magnetic Stimulation (cTBS) Effects in Generalized Epilepsy Patients.","phase":"NA","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Universitatea de Stat de Medicina si Farmacie Nicolae Testemiţanu","has_results":false},{"nct_id":"NCT04965571","title":"Clinical Features and Outcome of Wilson's Disease With Generalized Epilepsy in Chinese Patients","phase":"","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT06769659","title":"A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"NeuroPro Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03955432","title":"Long-term Cardiac Monitoring in Epilepsy","phase":"NA","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Northwell Health","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}